Sharon Hodgson MP: written questions 2025
91 published records · newest first.
Written questions
Hernias: Surgical Mesh ImplantsDepartment of Health and Social CareTabled 29 Aug 2025AnsweredUIN 70366More
Question: To ask the Secretary of State for Health and Social Care, whether the National Institute for Health and Care Excellence plans to publish updated guidance on the eight types of hernia mesh.
Answer: Topics for new or updated guidance from the National Institute for Health and Care Excellence (NICE) are considered through the NICE prioritisation process. Decisions as to whether NICE will create new, or update existing, guidance are overseen by an inte...
Answered 10 Sept 2025
Original Parliament recordFoetal Valproate Spectrum DisorderDepartment of Health and Social CareTabled 29 Aug 2025AnsweredUIN 70365More
Question: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 August 2025 to Question 65738 on Foetal Valproate Spectrum Disorder, if he will make interim payments to valproate families following the end of the pilot project.
Answer: The NHS England-commissioned Fetal Exposure to Medicine Pilot project covers assessment, expert advice, and treatment planning for people impacted by sodium valproate and other anti-seizure medications.On the question of interim payments to valproate fami...
Answered 9 Sept 2025
Original Parliament recordSurgical Mesh ImplantsDepartment of Health and Social CareTabled 29 Aug 2025AnsweredUIN 70364More
Question: To ask the Secretary of State for Health and Social Care, what the outcome was of the MHRA rectopexy review.
Answer: At the end of 2024, the Medicines and Healthcare products Regulatory Agency (MHRA) completed its’ first stage review into the use of mesh in rectopexy procedures, which involved a comprehensive review of the mesh products available in Great Britian’s mark...
Answered 9 Sept 2025
Original Parliament recordSurgical Mesh ImplantsDepartment of Health and Social CareTabled 29 Aug 2025AnsweredUIN 70363More
Question: To ask the Secretary of State for Health and Social Care, if there is a Hospital Episode Statistics code used to record instances of mesh used for rectopexy.
Answer: The latest National Clinical Coding Standards, code OPCS-4 2025, which are used in the Hospital Episode Statistics dataset to capture procedure information, includes four codes for use where a procedure concerns the insertion or removal of a mesh. These s...
Answered 9 Sept 2025
Original Parliament recordLow Alcohol Drinks: PricesDepartment for Environment, Food and Rural AffairsTabled 29 Aug 2025AnsweredUIN 70362More
Question: To ask the Secretary of State for Environment, Food and Rural Affairs, whether he has held discussions with (a) retailers and (b) producers on the pricing of alcohol-free drinks.
Answer: Defra regularly engages with supermarkets and producers on a range of food supply matters. However, it is not for the Government to set retail food and drink prices nor to comment on day-to-day commercial decisions taken by businesses.
Answered 5 Sept 2025
Original Parliament recordLow Alcohol Drinks: PricesDepartment for Environment, Food and Rural AffairsTabled 29 Aug 2025AnsweredUIN 70361More
Question: To ask the Secretary of State for Environment, Food and Rural Affairs, whether his Department has made an assessment of for what reason alcohol-free drinks are priced (a) comparably to and (b) higher than alcoholic equivalents.
Answer: Defra regularly engages with supermarkets and producers on a range of food supply matters. However, it is not for the Government to set retail food and drink prices nor to comment on day-to-day commercial decisions taken by businesses.
Answered 5 Sept 2025
Original Parliament recordLow Alcohol Drinks: PricesTreasuryTabled 29 Aug 2025AnsweredUIN 70360More
Question: To ask the Chancellor of the Exchequer, whether she has considered the potential merits of (a) tax and (b) subsidy incentives in reducing the cost of alcohol-free drinks.
Answer: Alcohol-free drinks are already tax advantaged compared to alcoholic drinks because they do not attract alcohol duty, which is charged only on products containing 1.2% alcohol by volume (ABV) or more. This reflects the Government’s intentions to encourage...
Answered 5 Sept 2025
Original Parliament recordAlcoholic Drinks: PricesTreasuryTabled 29 Aug 2025AnsweredUIN 70359More
Question: To ask the Chancellor of the Exchequer, whether her Department has made an assessment of the potential impact of (a) VAT rates and (b) other fiscal measures on the relative pricing of (i) alcohol-free and (ii) alcoholic drinks.
Answer: Alcohol-free drinks are already tax advantaged compared to alcoholic drinks because they do not attract alcohol duty, which is charged only on products containing 1.2% alcohol by volume (ABV) or more. This reflects the Government’s intentions to encourage...
Answered 5 Sept 2025
Original Parliament recordAlcoholic Drinks: PricesDepartment of Health and Social CareTabled 29 Aug 2025AnsweredUIN 70358More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has had discussions with industry stakeholders on the pricing strategies of (a) alcohol-free drinks and (b) alcoholic beverages.
Answer: In Fit for the Future: 10 Year Health Plan for England, the Government has committed to tackling harmful levels of alcohol consumption through exploring options to encourage consumers to reduce their alcohol intake by substituting standard strength drinks...
Answered 4 Sept 2025
Original Parliament recordLow Alcohol Drinks: PricesDepartment of Health and Social CareTabled 29 Aug 2025AnsweredUIN 70357More
Question: To ask the Secretary of State for Health and Social Care, if he will hold discussions with (a) manufacturers and (b) retailers on improving the affordability of alcohol-free alternatives.
Answer: In Fit for the Future: 10 Year Health Plan for England, the Government has committed to tackling harmful levels of alcohol consumption through exploring options to encourage consumers to reduce their alcohol intake by substituting standard strength drinks...
Answered 4 Sept 2025
Original Parliament recordSpecial Educational NeedsDepartment for EducationTabled 15 Jul 2025AnsweredUIN 67854More
Question: To ask the Secretary of State for Education, what assessment she has made of the potential merits of continuing the use of Education, Health and Care Plans to support children who have Special Education Needs and Disabilities with a guaranteed right to su
Answer: The department is determined to restore confidence in the system of support for children and young people with special educational needs and disabilities (SEND), so that all children and young people get the chance to achieve and thrive in their education...
Answered 23 Jul 2025
Original Parliament recordAutism: Foetal Valproate Spectrum DisorderDepartment of Health and Social CareTabled 14 Jul 2025AnsweredUIN 67309More
Question: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 10 July 2025 to Question 63541 on Autism: Foetal Valproate Spectrum Disorder, if she will take steps to collate this information centrally.
Answer: Research already exists that shows evidence of an increased risk for children of neurodevelopmental disorders, such as autism, when exposed to Valproate during pregnancy. This includes the Medicines & Healthcare products Regulatory Agency’s publicatio...
Answered 28 Jul 2025
Original Parliament recordCancer: Health ServicesDepartment of Health and Social CareTabled 11 Jul 2025AnsweredUIN 66899More
Question: To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of appointing a Government lead to establish a strategic mission for (a) rare and (b) less survivable cancers.
Answer: We will get the National Health Service diagnosing cancer earlier and treating it faster so more patients survive, and we will improve patients’ experience across the systemThe Government supports Scott Arthur’s Private Members Bill on rare cancers. The b...
Answered 21 Jul 2025
Original Parliament recordPatient Safety CommissionerDepartment of Health and Social CareTabled 10 Jul 2025AnsweredUIN 66530More
Question: To ask the Secretary of State for Health and Social Care, for what reason the role of the Patient Safety Commissioner is now going to be hosted within the MHRA; and what assessment he has made of the potential impact of this on her ability to advocate for
Answer: Dr Dash’s review of patient safety across the health and care landscape was published in July 2025. The review sets out a broad aim to streamline, simplify, and consolidate functions across the patient safety landscape. Dr Dash made nine recommendations w...
Answered 18 Jul 2025
Original Parliament recordFoetal Valproate Spectrum Disorder: Health ServicesDepartment of Health and Social CareTabled 30 Jun 2025AnsweredUIN 63542More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the (a) experiences and (b) interests of (i) children with foetal valproate syndrome and (ii) their families are included in NHS reform.
Answer: As part of National Health Service reform, the Department has launched a transformation programme, led by a senior responsible officer. The Department is engaging with partners to ensure their experiences and interests are considered in shaping the future...
Answered 9 Jul 2025
Original Parliament recordAutism: Foetal Valproate Spectrum DisorderDepartment of Health and Social CareTabled 30 Jun 2025AnsweredUIN 63541More
Question: To ask the Secretary of State for Health and Social Care, how many children diagnosed with autistic spectrum disorders also have a diagnosis of foetal valproate syndrome.
Answer: Everyone who has been harmed from sodium valproate has our deepest sympathies. Information about the number of children diagnosed with an autistic spectrum disorder and a diagnosis of foetal valproate syndrome is not collected centrally.
Answered 10 Jul 2025
Original Parliament recordSodium Valproate: CompensationDepartment of Health and Social CareTabled 30 Jun 2025AnsweredUIN 63540More
Question: To ask the Secretary of State for Health and Social Care, whether he plans to respond to the Hughes Report before 23 July 2025.
Answer: The Government is carefully considering the work done by the Patient Safety Commissioner and her report, which set out options for redress for those harmed by valproate and pelvic mesh. This is a complex issue involving input from different Government dep...
Answered 9 Jul 2025
Original Parliament recordSchools: Adrenaline Auto-injectorsDepartment for EducationTabled 11 Jun 2025AnsweredUIN 58949More
Question: To ask the Secretary of State for Education, how many and what proportion of schools have administered adrenaline auto-injector devices to pupils experiencing anaphylaxis at school in each year since 2017.
Answer: The department does not hold this data.
Answered 19 Jun 2025
Original Parliament recordSodium Valproate: CompensationDepartment of Health and Social CareTabled 4 Jun 2025AnsweredUIN 57219More
Question: To ask the Secretary of State for Health and Social Care, for what reason (a) Valproate redress and (b) interim payments are delayed.
Answer: The Government is carefully considering the valuable work done by the Patient Safety Commissioner and the resulting Hughes Report, which set out options for redress for those harmed by valproate and pelvic mesh. This is a complex area of work, involving s...
Answered 11 Jun 2025
Original Parliament recordSoft Drinks: TaxationTreasuryTabled 22 May 2025AnsweredUIN 54238More
Question: To ask the Chancellor of the Exchequer, what assessment her Department has made of the potential merits of extending exemptions to the proposed lactose allowance for milk-based drinks to equivalent milk-substitute drinks as part of the Soft Drinks Industr
Answer: At Autumn Budget 2024 the Chancellor announced her intention to review the Soft Drinks Industry levy (SDIL) – which has incentivised producers to remove almost half (46%) the sugar in relevant drinks – to further drive product reformulation. The ‘Strength...
Answered 10 Jun 2025
Original Parliament recordCare Homes and Palliative Care: DrugsDepartment of Health and Social CareTabled 30 Apr 2025AnsweredUIN 49330More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of controls on stocking (a) palliative care medicines and (b) controlled drugs on the (i) adequacy of access to medication for patien
Answer: Under the Enhanced health in care homes framework, every care home must be aligned to a primary care network (PCN) and must have established protocols between the PCN, the care home, and system partners, such as local general practices and pharmacies, for...
Answered 8 May 2025
Original Parliament recordCare Homes and Palliative Care: DrugsDepartment of Health and Social CareTabled 30 Apr 2025AnsweredUIN 49329More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of access to (a) palliative care medicines and (b) controlled drugs for patients in care homes.
Answer: Under the Enhanced health in care homes framework, every care home must be aligned to a primary care network (PCN) and must have established protocols between the PCN, the care home, and system partners, such as local general practices and pharmacies, for...
Answered 8 May 2025
Original Parliament recordCare Homes: DrugsHome OfficeTabled 28 Apr 2025AnsweredUIN 48379More
Question: To ask the Secretary of State for the Home Department, what steps she is taking to help increase uptake levels of the license for access to controlled drugs in UK care homes with nursing provision.
Answer: Most care homes will not require a licence to access medicines containing controlled drugs for patients who need them. This is because care homes run by public authorities or charities are exempt from the need for a licence. In addition, all care homes wi...
Answered 9 May 2025
Original Parliament recordCare Homes: DrugsHome OfficeTabled 28 Apr 2025AnsweredUIN 48378More
Question: To ask the Secretary of State for the Home Department, what assessment she has made of the adequacy of the existing licensing scheme for access to controlled drugs in UK care homes.
Answer: Most care homes will not require a licence to access medicines containing controlled drugs for patients who need them. This is because care homes run by public authorities or charities are exempt from the need for a licence. In addition, all care homes wi...
Answered 9 May 2025
Original Parliament recordOvarian Cancer: DiagnosisDepartment of Health and Social CareTabled 22 Apr 2025AnsweredUIN 46695More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of misdiagnosis of women’s health symptoms on levels of diagnosis of ovarian cancer in (a) all women and (b) women under the age of 5
Answer: The Government is committed to improving the diagnosis, treatment, and ongoing care of gynaecological conditions, including ovarian cancer. NHS England has taken urgent action to address gynaecology waiting lists through the Elective Recovery Plan, includ...
Answered 2 May 2025
Original Parliament record
Published records only — not a full account of an MP’s work. How we work →